These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8038363)

  • 1. [Characteristics of cerebral and peripheral vasodilators consumption in primary care].
    Arto Serrano A; Royo Serrano M; Busquet Martínez J; Marín Ibáñez A
    Aten Primaria; 1994 May; 13(8):419-24. PubMed ID: 8038363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prescription of cerebral and peripheral vasodilators in primary health care: a study in the health district of Bilbao].
    Ibáñez Pérez F; Olaskoaga Arrate A
    Aten Primaria; 1994; 14(3):665-70. PubMed ID: 8086585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autonomy attitudes in the treatment compliance of a cohort of subjects with continuous psychotropic drug administration].
    Baumann M; Trincard M
    Encephale; 2002; 28(5 Pt 1):389-96. PubMed ID: 12386539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: an analysis of data from the National Ambulatory Medical Care Survey for 1996-2001.
    Rasu RS; Shenolikar RA; Nahata MC; Balkrishnan R
    Clin Ther; 2005 Dec; 27(12):1970-9. PubMed ID: 16507384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical considerations on the use of a drug with vasodilating hemokinetic action in cerebral and peripheral vascular diseases].
    Florio F; Ruffolo S; Piro E
    Minerva Cardioangiol; 1976 Feb; 24(2):161-70. PubMed ID: 1256656
    [No Abstract]   [Full Text] [Related]  

  • 6. How to use cerebral vasodilators and metabolic activators.
    Isozumi K; Izumi Y
    Tokai J Exp Clin Med; 1998 Oct; 23(4):187-92. PubMed ID: 10359509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug consumption by people over 60 years of age in a rural area].
    Vega Quiroga S; López Gay L; Bermejo Pareja F; de la Rosa Gil L; de Bustos Tabernero M; Sampedro López MD; Fraile Jimeno M; Durán Parra F; Moreno Sobrino T; Gabriel Sánchez R
    Aten Primaria; 1996 May; 17(8):496-500. PubMed ID: 8679886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Do the patients medicate themselves correctly?].
    Moral Serrano S; Aguarón Joven E; Adán Gil FM; Pons Pons L; Baquer Masgrau A; Viejo Navarro L
    Aten Primaria; 1994 Mar; 13(5):242-6. PubMed ID: 7654922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of purchase of antihypertensive and serum lipid-reducing drugs in Sweden--individual data from national registers.
    Silwer L; Lundborg CS; Petzold M
    Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):37-42. PubMed ID: 17987590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential drug-drug and drug-disease interactions in prescriptions for ambulatory patients over 50 years of age in family medicine clinics in Mexico City.
    Doubova Dubova SV; Reyes-Morales H; Torres-Arreola Ldel P; Suárez-Ortega M
    BMC Health Serv Res; 2007 Sep; 7():147. PubMed ID: 17880689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the therapy of cerebral and peripheral circulatory disorders in general practice].
    Risse S
    Med Welt; 1967 Jul; 28():1659-62. PubMed ID: 5612140
    [No Abstract]   [Full Text] [Related]  

  • 12. [Consumption of psychotropic drugs by the aged].
    García Fernández JJ; González Pérez C; Martín Sánchez MD; Sánchez Baragaño MA; Bernardo Vega J; Menéndez Rodríguez MA
    Rev Sanid Hig Publica (Madr); 1994; 68(2):303-10. PubMed ID: 7716419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Practical problems in the prescription of cerebral vasodilators].
    Delwaide PJ
    Rev Med Liege; 1974 Sep; 29(17):508-12. PubMed ID: 4428112
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of vasodilators on the cerebral circulation].
    Miyazaki M
    Naika; 1967 Jan; 19(1):141-5. PubMed ID: 6060632
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiences on the treatment of cerebral insufficiency and peripheral circulation disorders with the test preparation EP 50-100].
    Bock KJ
    Med Welt; 1972 Feb; 23(8):273-5. PubMed ID: 5012543
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Critical observations on vasodilator agents in peripheral vascular diseases and cerebrovascular disorders].
    Hamming JJ; van der Drift JH
    Ned Tijdschr Geneeskd; 1968 Mar; 112(13):611-4. PubMed ID: 5664995
    [No Abstract]   [Full Text] [Related]  

  • 18. [Factors associated with chronic drug consumption in the elderly].
    López-Torres Hidalgo J; Cerdá Díaz R; Fernández Olano C; Requena Gallego M; Fernández Casalderrey C; Otero Puime A
    Med Clin (Barc); 1997 Apr; 108(15):572-6. PubMed ID: 9280788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Utilization of medication by the elderly in Argentine].
    Iñesta García A; Navarro I; Anzola Pérez E; Fefer E
    Rev Esp Salud Publica; 1995; 69(3-4):315-27. PubMed ID: 8548680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Should cerebral vasodilators be prescribed? Introduction].
    Lecomte J
    Rev Med Liege; 1974 Sep; 29(17):489-90. PubMed ID: 4428108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.